Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hernan Carol

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Pediatric Blood & Cancer|May 18, 2011
Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing programRichard B Lock, Hernan Carol, Christopher L Morton, et al.
Pediatric Blood & Cancer|January 11, 2013
Initial testing (stage 1) of ganetespib, an Hsp90 inhibitor, by the Pediatric Preclinical Testing ProgramRichard B Lock, Hernan Carol, John M Maris, et al.
Pediatric Blood & Cancer|May 4, 2011
Initial testing (Stage 1) of AT13387, an HSP90 inhibitor, by the pediatric preclinical testing programMin H Kang, C Patrick Reynolds, Peter J Houghton, et al.
Pediatric Blood & Cancer|March 14, 2014
Initial testing (stage 1) of the investigational mTOR kinase inhibitor MLN0128 by the pediatric preclinical testing programMin H Kang, C Patrick Reynolds, John M Maris, et al.
Pediatric Blood & Cancer|May 31, 2016
Initial Testing (Stage 1) of MK-8242-A Novel MDM2 Inhibitor-by the Pediatric Preclinical Testing ProgramMin H Kang, C Patrick Reynolds, E Anders Kolb, et al.
Pediatric Blood & Cancer|November 5, 2011
Initial testing (stage 1) of SGI-1776, a PIM1 kinase inhibitor, by the pediatric preclinical testing programVandana Batra, John M Maris, Min H Kang, et al.
Pediatric Blood & Cancer|March 26, 2014
Initial testing (stage 1) of the notch inhibitor PF-03084014, by the pediatric preclinical testing programHernan Carol, John M Maris, Min H Kang, et al.
Pediatric Blood & Cancer|June 26, 2009
Initial testing (stage 1) of lapatinib by the pediatric preclinical testing programRichard Gorlick, E Anders Kolb, Peter J Houghton, et al.
Pediatric Blood & Cancer|January 22, 2013
Initial testing (stage 1) of temozolomide by the pediatric preclinical testing programStephen T Keir, John M Maris, C Patrick Reynolds, et al.
Pediatric Blood & Cancer|April 5, 2013
Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, C Patrick Reynolds, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Pediatric Blood & Cancer|May 18, 2011
Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing programRichard B Lock, Hernan Carol, Christopher L Morton, et al.
Pediatric Blood & Cancer|January 11, 2013
Initial testing (stage 1) of ganetespib, an Hsp90 inhibitor, by the Pediatric Preclinical Testing ProgramRichard B Lock, Hernan Carol, John M Maris, et al.
Pediatric Blood & Cancer|May 4, 2011
Initial testing (Stage 1) of AT13387, an HSP90 inhibitor, by the pediatric preclinical testing programMin H Kang, C Patrick Reynolds, Peter J Houghton, et al.
Pediatric Blood & Cancer|March 14, 2014
Initial testing (stage 1) of the investigational mTOR kinase inhibitor MLN0128 by the pediatric preclinical testing programMin H Kang, C Patrick Reynolds, John M Maris, et al.
Pediatric Blood & Cancer|May 31, 2016
Initial Testing (Stage 1) of MK-8242-A Novel MDM2 Inhibitor-by the Pediatric Preclinical Testing ProgramMin H Kang, C Patrick Reynolds, E Anders Kolb, et al.
Pediatric Blood & Cancer|November 5, 2011
Initial testing (stage 1) of SGI-1776, a PIM1 kinase inhibitor, by the pediatric preclinical testing programVandana Batra, John M Maris, Min H Kang, et al.
Pediatric Blood & Cancer|March 26, 2014
Initial testing (stage 1) of the notch inhibitor PF-03084014, by the pediatric preclinical testing programHernan Carol, John M Maris, Min H Kang, et al.
Pediatric Blood & Cancer|June 26, 2009
Initial testing (stage 1) of lapatinib by the pediatric preclinical testing programRichard Gorlick, E Anders Kolb, Peter J Houghton, et al.
Pediatric Blood & Cancer|January 22, 2013
Initial testing (stage 1) of temozolomide by the pediatric preclinical testing programStephen T Keir, John M Maris, C Patrick Reynolds, et al.
Pediatric Blood & Cancer|April 5, 2013
Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, C Patrick Reynolds, et al.
Pageof 7